ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980

Miami Radiotherapy Program Defended

June 30, 1978

M.D. Anderson Wins 11th SPORE Grant.

July 3, 2008

Straus asks to “Set Record Straight”

September 2, 1988

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008